Evaluating Ileostomy Hydration Protocol

Status Withdrawn

Clinical Trial Summary

This is a prospective observational study on patients who undergo an ileostomy creation after implementing a hydration algorithm as routine care at Robert Packer Hospital. The Department of Surgery will be implementing a protocol to prevent dehydration for patients with high output ileostomies. Patients with high output ileostomies are at an increased risk for readmission for dehydration. By reviewing the data after applying this standardized hydration protocol, we can assess its efficacy on readmission rates and comorbidities stemming from dehydration.

Clinical Trial Description

As of January 1, 2021, Robert Packer Hospital will implement a standardized hydration protocol for patients at high risk for readmission due to dehydration. All postoperative ileostomy patients will be provided the following instructions at the bedside to ensure complete comprehension: 1. Stoma maintenance education 2. Hydration recommendations 3. Intake and Output Worksheet education and trial The colorectal surgeons standardized the postoperative medical management of ileostomy output. Before discharge, the healthcare providers will complete a "Discharge Assessment Checklist". On the day of discharge, patients will be categorized by the "Discharge Algorithm for Patients with Ileostomies." The algorithm will assign patients by their ileostomy output and determine their next management steps. After discharge, all patients will record their fluid input and output using the "Daily Measurement of Intake/Output Worksheet" which will be used to monitor hydration over time. Patients who are high risk will receive outpatient intravenous hydration therapy. At each intravenous therapy appointment, the health care provider will review the Outpatient Intravenous Hydration Algorithm to determine the volume of fluid to distribute or if re-evaluation is necessary. Data Collection After starting the standardized hydration protocol, researchers will prospectively collect data from monthly reports of patients who received an ileostomy creation. Researchers will not mask the patients, care providers, investigators, and outcomes assessors. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04669964
Study type	Observational
Source	The Guthrie Clinic
Contact
Status	Withdrawn
Phase
Start date	January 1, 2023
Completion date	January 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04079543` - NPO and Patient Satisfaction in the Cath Lab	N/A
Recruiting	`NCT06063655` - Effects of Two Novel Hydration Beverage Formulas on Rehydration in Adults	N/A
Completed	`NCT05111392` - Hydration Dynamics and Influence of Beverage Composition	Phase 1/Phase 2
Terminated	`NCT02486224` - Metabolomic Analysis of the Impacts of Hydration Status on Exercise Performance	N/A
Recruiting	`NCT02249845` - Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children	N/A
Completed	`NCT01285713` - IV Glucose for Dehydration Treatment	Phase 2
Withdrawn	`NCT00691275` - Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration	N/A
Completed	`NCT00360204` - Improving Health Outcomes for New Mothers and Babies	Phase 3
Completed	`NCT00370968` - Zinc-ORS in Severe and Complicated Acute Diarrhea	Phase 2/Phase 3
Completed	`NCT04076995` - INDIGO-2: The Effect of High Water Intake on Glucose Regulation in Low-drinkers	N/A
Recruiting	`NCT05768789` - Buoy Electrolyte Study on Hydration Status of Active Men and Women	N/A
Not yet recruiting	`NCT05428228` - Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults	N/A
Completed	`NCT04997031` - Tap Water Intake and Perceptions in US Latinx Adults
Completed	`NCT04536324` - The Absorption Rate of Subcutaneous Infused Fluid
Completed	`NCT02926989` - Intravenous Fluids in Hospitalised Children	Phase 4
Completed	`NCT04874584` - Culturally Tailored Nurse Coaching Study for Cancer Symptom Management	N/A
Completed	`NCT02206581` - Using Hydration Monitor to Detect Changes in the Hydration Status Athletes	N/A
Completed	`NCT02265575` - Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration	Phase 2
Completed	`NCT01893853` - Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)	N/A
Completed	`NCT01503996` - Drinking Habits of Glaucoma Patients and Age Matched Controls	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.